Clinical trial
Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell…
NCT00494026 · Eli Lilly and Company, Industry · Terminated
Key facts
| NCT number | NCT00494026 |
|---|---|
| Title | Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) |
| Official title | Phase II Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage of Small Cell Lung Cancer |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Small Cell Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | pemetrexed, carboplatin, radiotherapy |
| Enrollment | 4 |
| Start date | Sep 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jun 29, 2007 |
| Last update posted | Nov 20, 2009 |
| Countries | Italy, Poland, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: